RedHill Biopharma commenced advanced clinical trial with RHB-103 (Migraine) (April 24 2012) English RedHill Biopharma commenced advanced clinical trial with RHB-103 (Migraine) (April 24 2012) Hebrew
Read More...News
RedHill announces successful pivotal BE trial results with RHB-102 (nausea and vomiting) – April 17, 2012 RedHill announces successful pivotal BE trial results with RHB-102 (nausea and vomiting) – Hebrew – April 17, 2012 See Dror Ben Asher (CEO) and Gilead Raday’s (VP Product Development) TV interview regarding RHB-102 trial results (Hebrew): http://www.bizportal.co.il/shukhahon/biznews02.shtml?mid=315186&strsrh=רדהיל
Read More...http://www.mfa.gov.il/MFA/InnovativeIsrael/No-more-nausea-after-chemo-1-Mar-2012
Read More...RedHill Biopharma commences advanced clinical trial with RHB-102 (Nausea and Vomiting) (February 14 2012) RedHill Biopharma commenced advanced clincial trial with RHB-102 (Nausea and Vomiting) (February 14 2012) Hebrew
Read More...RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012 RedHill Biopharma obtains FDA IND for advanced clinical trial with RHB-102 (Nausea and Vomiting) Feb 12th 2012 (Hebrew)
Read More...RedHill Biopharma obtains a CTA approval to commence an advanced trial with RHB-102 (prevention of nausea & vomiting) (February 5th 2012) RedHill Biopharma obtains a CTA approval to commence an advanced trial with RHB-102 (prevention of nausea & vomiting) (February 5th 2012) Hebrew
Read More...See Mr. Gilead Raday’s interview on Israel21c, regarding RHB-102 (prevention of nausea & vomiting in cancer patients): http://israel21c.org/health/daily-pill-to-vanquish-nausea-after-chemo
Read More...IntelGenx, RedHill’s Development Partner in RHB-103 (Migraine) Announces Health Canada Approval for Pivotal Trial
Read More...Please use the link below to watch Dr. Jeff Lehighton, RedHill Biopharma’s Chairman of the Advisory Board, on Bloomberg TV: http://www.bloomberg.com/video/80653140/
Read More...RedHill engages with CRO for potential pivotal trial with RHB-102 (Prevention of Nausea Vomiting ) (Hebrew) RedHill engages with CRO in preparation for potential pivotal trial with RHB-102 (prevention of nausea & vomiting )
Read More...